Fig. 1From: EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancerCONSORT diagram illustrating the disposition to treatment arms, plus reasons for discontinuing treatment on trialBack to article page